Repositioning imatinib for spinal cord injury
Authors:
Open Access
- 1 January 2015
- journal article
- perspective
- Published by Medknow in Neural Regeneration Research
- Vol. 10 (10) , 1591-3
Abstract
Neural Regen Res, Official publication of Publishing House of Neural Regeneration Research China Association of Rehabilitation Medicine,ChinaKeywords
This publication has 11 references indexed in Scilit:
- Delayed Imatinib Treatment for Acute Spinal Cord Injury: Functional Recovery and Serum BiomarkersJournal of Neurotrauma, 2015
- Rationale, design and critical end points for the Riluzole in Acute Spinal Cord Injury Study (RISCIS): a randomized, double-blinded, placebo-controlled parallel multi-center trialSpinal Cord, 2015
- Systemic administration of epothilone B promotes axon regeneration after spinal cord injuryScience, 2015
- Altering spinal cord excitability enables voluntary movements after chronic complete paralysis in humansBrain, 2014
- Characterization of Vascular Disruption and Blood–Spinal Cord Barrier Permeability following Traumatic Spinal Cord InjuryJournal of Neurotrauma, 2014
- Imatinib Ameliorates Neuroinflammation in a Rat Model of Multiple Sclerosis by Enhancing Blood-Brain Barrier Integrity and by Modulating the Peripheral Immune ResponsePLOS ONE, 2013
- Imatinib Enhances Functional Outcome after Spinal Cord InjuryPLOS ONE, 2012
- Different immunoprofiles in patients with chronic myeloid leukemia treated with imatinib, nilotinib or dasatinibLeukemia & Lymphoma, 2012
- A Pericyte Origin of Spinal Cord Scar TissueScience, 2011
- A Quantitative Spatial Analysis of the Blood–Spinal Cord BarrierExperimental Neurology, 1996